RadNet, Inc.

NASDAQ•RDNT

CEO: Dr. Howard G. Berger M.D.

セクター: Healthcare

業種: Medical - Diagnostics & Research

上場日: 1997-01-03

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

連絡先情報

1510 Cotner Avenue, Los Angeles, CA, 90025, United States

310-478-7808

www.radnet.com

時価総額

$4.94B

PER (TTM)

-256.5

28.1

配当利回り

52週高値

$85.84

52週安値

$45.00

52週レンジ

46%

順位58Top 85.6%

2.3

F-Score

改良版 Piotroski 分析

10年ファンダメンタル

弱い • 2.3 / 9 ポイント

スコアレンジ (0-9)

8-9: 価値が優れている

6-7: 基礎体質が強い

4-5: 全体的に堅調

0-3: パフォーマンスが弱い

データ期間: 2016-2025

財務ダッシュボード

Q4 2025 データ

売上高

$547.71M+0.00%

直近4四半期の推移

EPS

-$0.01+0.00%

直近4四半期の推移

フリーCF

-$230.86M+0.00%

直近4四半期の推移

2025 Annual 決算ハイライト

主なハイライト

Total Revenue Rises 10.9% Consolidated revenue reached $2.040 B USD in 2025, marking a 10.9% increase driven by higher fees and volumes.

Imaging Center Revenue Grows Imaging Center revenue increased 10.9% to $1.988 B USD, fueled by organic growth and 20 centers acquired in 2025.

Digital Health Revenue Accelerates Digital Health segment revenue jumped 41.1% to $92.7 M USD, reflecting integration of iCAD and other AI acquisitions.

Operating Cash Flow Improves Cash provided by operating activities increased $65.8 M USD to $298.8 M USD, driven by favorable working capital changes.

リスク要因

Net Loss Attributable Stockholders Net loss attributable to common stockholders was $(18.652) M USD in 2025, reversing prior year's net income.

Digital Health Segment Losses Widen Digital Health segment operating loss widened to $(32.297) M USD due to integration costs and ongoing investment scaling.

Fixed Costs Pressure Margins High fixed costs combined with potential reimbursement rate reductions could materially reduce operating profitability going forward.

Cybersecurity Threats Remain High Cybersecurity risks, including ransomware, pose threats to operations, data integrity, and could cause significant financial hardship.

見通し

Expand Networks Via Acquisitions Plans focus on strengthening market presence through organic expansion and disciplined acquisition of new imaging centers.

Leverage AI Technology Investment Continue deploying DeepHealth OS and AI solutions to enhance operational efficiency and improve diagnostic quality across services.

Optimize Profitable Contracting Strategy includes regular evaluation and renegotiation of payor contracts to improve revenue terms and reduce overall expenses.

Scale Commercial Digital Health Intent to scale commercial Digital Health business, building on global customer base expansion to over 2,000 organizations.

同業比較

売上高 (TTM)

OSCR

$11.70B

+27.5%

BLCO

$5.10B

+6.5%

BRKR

$3.44B

+2.1%

粗利益率 (最新四半期)

KRYS

89.8%

+2.2pp

IRTC

70.9%

+2.3pp

BLCO

58.1%

-1.0pp

主要指標

銘柄コード	時価総額	PER (TTM)	ROE (TTM)	負債比率
PCVX	$7.98B	-9.8	-25.9%	7.5%
KRYS	$7.49B	36.2	18.7%	0.7%
BLCO	$5.92B	-16.4	-5.6%	38.3%

長期トレンド

直近4四半期

売上高

純利益

営業キャッシュフロー

4四半期売上高CAGR

5.1%

安定成長

4四半期純利益CAGR

N/M

収益構造の変化

キャッシュフロー安定性

100%

優れたキャッシュフローの実績

深度リサーチ

次回決算:2026年5月7日

EPS:-

売上高:-

財務データ

決算説明会

財務レポート

ニュース

損益計算書

バランスシート

キャッシュフロー計算書

財務比率

変化率

損益計算書	直近12ヶ月

データなし